To establish a treatment for GI symptoms of cystic fibrosis, it is necessary to develop a symptom evaluation tool
暂无分享,去创建一个
[1] K. Whelan,et al. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders , 2019, United European gastroenterology journal.
[2] M. Currie,et al. High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[3] P. Jaksch,et al. Impact of nutritional status on pulmonary function after lung transplantation for cystic fibrosis , 2018, United European gastroenterology journal.
[4] S. Fukudo,et al. Randomized, double‐blind, placebo‐controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[5] M. Boermeester,et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) , 2017, United European gastroenterology journal.
[6] D. Drossman,et al. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. , 2016, Gastroenterology.
[7] R. Spiller,et al. Bowel Disorders. , 2016, Gastroenterology.
[8] T. Hibi,et al. Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial , 2012, Journal of neurogastroenterology and motility.
[9] T. Hibi,et al. Classification of functional dyspepsia based on concomitant bowel symptoms , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.